Who we serve · Pharma / devices / biotech
The medicine launched. The patients never arrived.
We are your patient support execution partner in Taiwan: program design, compliance infrastructure and outcome data — PAP, PSP and EAP delivered from one place.
Book a discovery call01
Problem → answer
After launch, the self-pay price loses the patient in the consulting room
PAP support: donation, co-pay assistance and installments lower the decision threshold enough to start
PAP · MediPASS payments
Donations tracked in spreadsheets and paper signatures leave nothing to show at HQ audit
GDP-compliant dispensing: batch, expiry, distribution and audit trail, all digital
MediPASS M3 dispensing
Patients stop after two months and the outcome data suffers
PSP care support: nurse hotline, education push and proactive outreach to at-risk patients
PSP · MediPASS M5 tickets
For unlicensed items, neither patient nor physician can find a compliant route
EAP import: source comparison, TFDA application, GDP transport and delivery tracking
EAP · NPP
The program runs, but no one can prove what it achieved
Dashboard: enrollment funnel, adherence, completion rate and cost analysis
MediPASS M6 dashboard
92%
program completion rate
18 days
average program launch lead time
100%
of donated stock fully traceable
120+
global pharma programs delivered
02
What clients say
"Donations used to live in spreadsheets and paper signatures, and audits meant digging through boxes. Now every pack is traced from intake to patient — HQ passed us first time."
"Patients don't want to stop treatment — they can't carry the cost. After we launched installments, the month-three continuation rate moved more than we expected."
03
How we work together
01
Discovery
Clarify the product, patient population and budget frame
02
Program design
Payment rules, eligibility criteria and compliance review
03
Platform setup
MediPASS configuration, pharmacy network and training
04
Run and refine
Monthly reporting, audit support and iteration
Give us 30 minutes before you decide
We start from your product and patient population, and tell you which kind of support program would actually work.